search
Back to results

Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Unicondylar Knee Arthroplasty (UKA) Procedures (CORI RCT UKA)

Primary Purpose

Non-inflammatory Degenerative Joint Disease, Including Osteoarthritis, Avascular Necrosis, Requires Correction of Functional Deformity

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
CORI
Conventional
Sponsored by
Smith & Nephew, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Non-inflammatory Degenerative Joint Disease, Including Osteoarthritis focused on measuring osteoarthritis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Subject is a suitable candidate for a UKA procedure using CORI and a S+N Knee compatible implant system.
  • Subject requires a cemented UKA as a primary indication that meets any of the following conditions:
  • Non-inflammatory degenerative joint disease, including osteoarthritis
  • Avascular necrosis
  • Requires correction of functional deformity
  • Requires treatment of fractures that were unmanageable using other techniques
  • Subject is of legal age to consent and considered skeletally mature (≥ 18 years of age at the time of surgery)
  • Subject agrees to consent to and to follow the study visit schedule (as defined in the study protocol and informed consent form), by signing the Ethics Committee (EC) or Institutional Review Board (IRB) approved informed consent form.
  • Subject plans to be available through one (1) year postoperative follow-up.
  • Applicable routine radiographic assessment is possible.

Exclusion Criteria:

  • Subject receives a UKA on the index joint as a revision for a previously failed surgery, or need for complex implants, or any other implant than a standard UKA (e.g. stems, augments, or custom made devices).
  • Subject has been diagnosed with post-traumatic arthritis
  • Subject receives bilateral UKA OR a unilateral UKA with contralateral TKA.
  • Subject does not understand the language used in the Informed Consent Form.
  • Subject does not meet the indication or is contraindicated for UKA according to specific S+N knee system's Instructions For Use (IFU).
  • Subject has active infection or sepsis (treated or untreated).
  • Subject is morbidly obese with a body mass index (BMI) greater than 40.
  • Subject is pregnant or breast feeding at the time of surgery.
  • Subject, in the opinion of the Investigator, has advanced osteoarthritis or joint disease at the time of surgery and was better suited for an alternate procedure.
  • Subject has a condition(s) that may interfere with the UKA survival or outcome (i.e., Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease, or an active, local infection).
  • Subject in the opinion of the Investigator has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation, drug or alcohol abuse.
  • Subject, in the opinion of the Investigator, has a neuromuscular disorder that prohibited control of the index joint.
  • Subject is a prisoner or meets the definition of a Vulnerable Subject per ISO 14155:2011 Section 3.44.

Sites / Locations

  • Northern HospitalRecruiting
  • The Prince of Wales HospitalRecruiting
  • North Shore HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

CORI UKA

Conventional UKA

Arm Description

Subjects in need for unicondylar knee arthroplasty (UKA) as decided by their doctor and treated with CORI.

Subjects in need for unicondylar knee arthroplasty (UKA) as decided by their doctor and treated with conventional approach with conventional manual instrumentation.

Outcomes

Primary Outcome Measures

Post-operative leg alignment
Post-operative leg alignment via radiographic assessment. Post-operative leg alignment is achieved when the deviation from the subject specific target does not exceed ±3 degrees.

Secondary Outcome Measures

Component Alignment
Component alignment will be assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery
Radiographic assessment
Radiographic assessment on antero-posterior (A/P) and lateral (L) views shall be performed to identify the presence of radiolucent lines, osteolysis & implant migration.
2011 Knee Society Score (KSS)
The Knee Society Score (KSS) is a validated tool combining objective physician-derived component with a subjective subject-derived component consisting of 36 questions & provides sub-scores across 4 dimensions. The Objective Knee Score rated by clinician assesses UKA alignment, stability, Range of Motion (ROM) and symptoms. The Subject Satisfaction Score assesses 5 daily activities: sitting, lying in bed, getting out of bed, light household duties, & leisure activities). The Subject Expectation Score evaluates the subject's expectations prior to surgery. Post-operative questions differ from pre-operative questions and ask if the subject's pre-operative expectations were met. Pre-op & post-op scores because they are based on different questions. The Functional Knee Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities.
Oxford Knee Score (OKS)
The Oxford Knee Score (OKS) is a Patient Reported Outcome questionnaire that was developed to assess perceived function and pain answered on a Likert scale after Total Knee Arthroplasty. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.
Forgotten Joint Score (FJS)
The Forgotten Joint Score (FJS) comprises measures for the assessment of joint-specific patient reported outcomes. Subjects are asked to rate their awareness of their knee arthroplasty in 12 questions with a five point Likert response format: "Never", "almost never", "seldom", "sometimes" and "mostly". The item scores are summed and linearly transformed in a 0 to 100 scale with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living.
Five-level EuroQol five-dimensional (EQ-5D-5L) VAS and index scores
The EQ-5D-5L score consists of two parts: a descriptive system and a visual analogue scale (VAS). The descriptive system is used to describe the subject's health state and consists of five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels to choose the most appropriate answer: no problems, slight problems, moderate problems, severe problems and extreme problems. The subject is asked to indicate his/her health state by marking the most appropriate statement in each of the five areas. The visual analogue scale records the subject's self-rated health on a vertical visual analogue scale. The endpoints on the scale are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS can be used as a quantitative measure of health outcome as judged by the individual respondents.

Full Information

First Posted
March 12, 2021
Last Updated
September 20, 2023
Sponsor
Smith & Nephew, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT04797897
Brief Title
Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Unicondylar Knee Arthroplasty (UKA) Procedures
Acronym
CORI RCT UKA
Official Title
A Prospective, Multi-center, Randomized Controlled Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Unicondylar Knee Arthroplasty (UKA) Procedures
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 12, 2022 (Actual)
Primary Completion Date
November 30, 2026 (Anticipated)
Study Completion Date
January 29, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Smith & Nephew, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a prospective study to demonstrate the safety and effectiveness of CORI and to register CORI in China mainland.
Detailed Description
This is a prospective, multi-center, randomized study to demonstrate the safety and effectiveness of CORI. In addition, the study will support regulatory approval by the National Medical Products Administration (NMPA) in China. The study will have two arms, the investigational group will be total knee arthroplasty (TKA) using CORI, the comparison group will be conventional approach with conventional manual instrumentation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Non-inflammatory Degenerative Joint Disease, Including Osteoarthritis, Avascular Necrosis, Requires Correction of Functional Deformity, Requires Treatment of Fractures That Were Unmanageable Using Other Techniques
Keywords
osteoarthritis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
140 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
CORI UKA
Arm Type
Experimental
Arm Description
Subjects in need for unicondylar knee arthroplasty (UKA) as decided by their doctor and treated with CORI.
Arm Title
Conventional UKA
Arm Type
Active Comparator
Arm Description
Subjects in need for unicondylar knee arthroplasty (UKA) as decided by their doctor and treated with conventional approach with conventional manual instrumentation.
Intervention Type
Device
Intervention Name(s)
CORI
Intervention Description
unicondylar knee arthroplasty (UKA) treated with CORI
Intervention Type
Device
Intervention Name(s)
Conventional
Intervention Description
unicondylar knee arthroplasty (UKA) treated with conventional approach with conventional manual instrumentation
Primary Outcome Measure Information:
Title
Post-operative leg alignment
Description
Post-operative leg alignment via radiographic assessment. Post-operative leg alignment is achieved when the deviation from the subject specific target does not exceed ±3 degrees.
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Component Alignment
Description
Component alignment will be assessed on long leg standing antero-posterior (A/P) X-rays and standard non weight bearing lateral X-rays taken 6 weeks after surgery
Time Frame
6 weeks
Title
Radiographic assessment
Description
Radiographic assessment on antero-posterior (A/P) and lateral (L) views shall be performed to identify the presence of radiolucent lines, osteolysis & implant migration.
Time Frame
12 months
Title
2011 Knee Society Score (KSS)
Description
The Knee Society Score (KSS) is a validated tool combining objective physician-derived component with a subjective subject-derived component consisting of 36 questions & provides sub-scores across 4 dimensions. The Objective Knee Score rated by clinician assesses UKA alignment, stability, Range of Motion (ROM) and symptoms. The Subject Satisfaction Score assesses 5 daily activities: sitting, lying in bed, getting out of bed, light household duties, & leisure activities). The Subject Expectation Score evaluates the subject's expectations prior to surgery. Post-operative questions differ from pre-operative questions and ask if the subject's pre-operative expectations were met. Pre-op & post-op scores because they are based on different questions. The Functional Knee Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities.
Time Frame
from pre-operative visit up to 12 months post-surgery
Title
Oxford Knee Score (OKS)
Description
The Oxford Knee Score (OKS) is a Patient Reported Outcome questionnaire that was developed to assess perceived function and pain answered on a Likert scale after Total Knee Arthroplasty. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.
Time Frame
from pre-operative visit up to 12 months post-surgery
Title
Forgotten Joint Score (FJS)
Description
The Forgotten Joint Score (FJS) comprises measures for the assessment of joint-specific patient reported outcomes. Subjects are asked to rate their awareness of their knee arthroplasty in 12 questions with a five point Likert response format: "Never", "almost never", "seldom", "sometimes" and "mostly". The item scores are summed and linearly transformed in a 0 to 100 scale with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living.
Time Frame
from operative visit up to 12 months post-surgery
Title
Five-level EuroQol five-dimensional (EQ-5D-5L) VAS and index scores
Description
The EQ-5D-5L score consists of two parts: a descriptive system and a visual analogue scale (VAS). The descriptive system is used to describe the subject's health state and consists of five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels to choose the most appropriate answer: no problems, slight problems, moderate problems, severe problems and extreme problems. The subject is asked to indicate his/her health state by marking the most appropriate statement in each of the five areas. The visual analogue scale records the subject's self-rated health on a vertical visual analogue scale. The endpoints on the scale are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS can be used as a quantitative measure of health outcome as judged by the individual respondents.
Time Frame
from pre-operative visit up to 12 months post surgery
Other Pre-specified Outcome Measures:
Title
CORI system time and cutting time of the robotic drill
Description
In the case logs, the following time stamps will be recorded in the log file of the CORI Case Report: State-Machine transition : [ Adjust Camera ] --> [ Checkpoint Definition ] State-Machine transition : [ Checkpoint Verification ] --> [ Remove Bone ] State-Machine transition : [ Remove Bone ] --> [ Baseline Stress ROM Collection ] CORI System Time CORI System starts with the checkpoint definition until the bone is removed. This is calculated by the time difference between #3 and #1. Cutting Time The Cutting Time of the robotic drill is the time from the start until the end of bone removal and is calculated by the time difference between #3 and #2.
Time Frame
During Operation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subject is a suitable candidate for a UKA procedure using CORI and a compatible S+N Knee implant system. Subject requires a cemented UKA as a primary indication that meets any of the following conditions: Non-inflammatory degenerative joint disease, including osteoarthritis Avascular necrosis Requires correction of functional deformity Requires treatment of fractures that were unmanageable using other techniques Subject is of legal age to consent and considered skeletally mature (≥ 18 years of age at the time of surgery). Subject agrees to consent to and to follow the study visit schedule (as defined in the study protocol and informed consent form), by signing the Ethics Committee (EC) or Institutional Review Board (IRB) approved informed consent form. Subject plans to be available through one (1) year postoperative follow-up. Applicable routine radiographic assessment if possible. Exclusion Criteria: Subject receives a UKA on the index joint as a revision for a previously failed surgery, or need for complex implants, or any other implant than a standard UKA (e.g. stems, augments, or custom made devices). Subject has been diagnosed with post-traumatic arthritis Subject receives simultaneous bilateral UKA OR a unilateral UKA with contralateral TKA. Subject has one or more of the following arthroplasties that are not fully healed and well-functioning, as determined by the investigator:-Contralateral primary TKA or UKA, however, the subject can only have one knee enrolled in this study. Subject does not understand the language used in the Informed Consent Form. Subject does not meet the indication or is contraindicated for UKA according to specific S+N knee system's Instructions For Use (IFU). Subject has active infection or sepsis (treated or untreated). Subject is morbidly obese with a body mass index (BMI) greater than 40. Subject is pregnant or breast feeding at the time of surgery. Subject, in the opinion of the Investigator, has advanced osteoarthritis or joint disease at the time of surgery and was better suited for an alternate procedure. Subject currently enrolled in another orthopedic clinical trial study. Subject has a condition(s) that may interfere with the UKA survival or outcome (i.e., Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease, or an active, local infection). Subject in the opinion of the Investigator has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, intellectual disability, drug or alcohol abuse. Subject, in the opinion of the Investigator, has a neuromuscular disorder that prohibited control of the index joint. Subject is a prisoner or meets the definition of a Vulnerable Subject per ISO 14155:2020 Section 3.55.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Manvendra Saxena, PhD
Phone
+61 455 870 175
Email
Manvendra.Saxena@smith-nephew.com
First Name & Middle Initial & Last Name or Official Title & Degree
Jack Cramer
Phone
+61460727771
Email
Jack.Cramer@Smith-Nephew.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Julie Lankiewicz
Organizational Affiliation
Smith & Nephew, Inc.
Official's Role
Study Director
Facility Information:
Facility Name
Northern Hospital
City
Epping
ZIP/Postal Code
3076
Country
Australia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vicky Kartsogiannis
Email
Vicky.Kartsogiannis@nh.org.au
First Name & Middle Initial & Last Name & Degree
Justin Wong
Facility Name
The Prince of Wales Hospital
City
Sha Tin
Country
Hong Kong
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stacy Lok
Email
lokszeyam@cuhk.edu.hk
First Name & Middle Initial & Last Name & Degree
Kevin Ho
Facility Name
North Shore Hospital
City
Auckland
ZIP/Postal Code
0620
Country
New Zealand
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Simon Young
Email
simon.young@auckland.ac.nz
First Name & Middle Initial & Last Name & Degree
Simon Young

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Unicondylar Knee Arthroplasty (UKA) Procedures

We'll reach out to this number within 24 hrs